Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eos Partners
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Eos Partners is a U.S.-based alternative investment firm focused on private equity, credit, and public equity investing rather than drug development or healthcare operations. Founded in 1994, the firm invests primarily in lower middle market companies at business inflection points and works with management teams to support growth and value creation. Public descriptions of the firm emphasize flexible capital deployment across multiple asset classes and a broad, generalist investment mandate. Although Eos has invested in companies across many sectors, it is not itself a biotech, pharma, life science, or healthcare company.
- Industry
- Investors
Beyond the preview
Go deeper on Eos Partners.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eos Partners.